Stranzenbach, R., Dippel, E., Schlaak, M. and Stadler, R. (2018). Alternate dosing regimens of brentuximab vedotin for CD30+cutaneous T-cell lymphoma: reply from the authors. Br. J. Dermatol., 178 (1). S. 303 - 304. HOBOKEN: WILEY. ISSN 1365-2133

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Stranzenbach, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dippel, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlaak, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stadler, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-200141
DOI: 10.1111/bjd.15972
Journal or Publication Title: Br. J. Dermatol.
Volume: 178
Number: 1
Page Range: S. 303 - 304
Date: 2018
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1365-2133
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ALEMTUZUMABMultiple languages
DermatologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/20014

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item